NGL Fine-Chem Competitors and Similar CompaniesClear all

NGL Fine-Chem's competitors and similar companies include Magpharm Laboratoires, Mepro Pharmaceuticals, Sami-Sabinsa Group and Ipca Laboratories.

	NGL Fine-Chem NGL Fine-Chem is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health.	Magpharm Laboratoires Magpharm Laboratoires is a company that designs and develops pharmaceutical products.	Mepro Pharmaceuticals Mepro Pharmaceuticals is a pharmaceutical company.	Sami-Sabinsa Group Sami-Sabinsa Group (formerly Sami Labs) is a manufacturer and supplier of herbal extracts.	Ipca Laboratories Ipca Laboratories is a pharmaceutical company.
Founding Date	Founding Date 1981	Founding Date N/A	Founding Date 1982	Founding Date 1991	Founding Date 1949
Type	Type Public	Type Private	Type Private	Type Private	Type Public
Tags	Tags Healthcare pharma supplements	Tags Healthcare pharma supplements	Tags Healthcare pharma supplements	Tags Healthcare pharma supplements	Tags Healthcare pharma supplements
Locations	Locations Mumbai, IN HQ	Locations Kouba, DZ HQ	Locations Mumbai, IN HQ Rajkot, IN Surendranagar, IN Vadodara, IN	Locations Bengaluru, IN HQ Woolloomooloo, AU Mississauga, CA Nanjing, CN Langen (Hessen), DE Toshima City, JP see more	Locations Mumbai, IN HQ Ankleshwar, IN Aurangabad, IN Boisar, IN Indore, IN Mumbai, IN Navi Mumbai, IN see more
Employees	Employees 380	Employees 4562% increase	Employees 4131% increase	Employees 7211% increase	Employees 17,335
Financial
Revenue (est.)	Revenue (est.) ₹5b (FY, 2026)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ₹96.5b (FY, 2026)
Cost of goods	Cost of goods ₹2.4b (FY, 2026)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods ₹28.2b (FY, 2026)
Gross profit	Gross profit ₹2.8b (FY, 2026)	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit ₹70b (FY, 2026)
Net income	Net income ₹481.3m (FY, 2026)	Net income N/A	Net income N/A	Net income N/A	Net income ₹11.9b (FY, 2026)